Electrophysiologic effects of cigarette smoking in patients with and without chronic beta-blocker therapy

After refraining from smoking for at least 8 hours, 22 adult male habitual smokers underwent baseline electrophysiologic study including atrial and ventricular burst pacing and programmed premature stimulation with single extrastimuli. After smoking 2 of their usual brand of cigarettes in rapid succ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 1987-11, Vol.60 (13), p.1078-1082
Hauptverfasser: Peters, Robert W., Benowitz, Neal L., Valenti, Steven, Modin, Gunnard, Fisher, Michael L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1082
container_issue 13
container_start_page 1078
container_title The American journal of cardiology
container_volume 60
creator Peters, Robert W.
Benowitz, Neal L.
Valenti, Steven
Modin, Gunnard
Fisher, Michael L.
description After refraining from smoking for at least 8 hours, 22 adult male habitual smokers underwent baseline electrophysiologic study including atrial and ventricular burst pacing and programmed premature stimulation with single extrastimuli. After smoking 2 of their usual brand of cigarettes in rapid succession, the electrophysiologic protocol was repeated. Nicotine, catecholamine and carbon monoxide concentrations all increased significantly. Smoking increased heart rate and improved atrioventricular conduction in the 13 patients receiving chronic β-blocker therapy (mostly for angina pectoris); increases in heart rate and improvement in atrioventricular conduction were not different statistically from those seen in patients not receiving β-blocker therapy, suggesting the possibility of a direct effect of nicotine or other components of tobacco smoke. Ventricular refractoriness was not altered and atrial and ventricular arrhythmias were not increased by smoking. Persistent sympathomimetic actions of cigarette smoking may explain in part the failure of β-blocking drugs to reduce cardiac mortality risk in smokers after myocardial infarction.
doi_str_mv 10.1016/0002-9149(87)90356-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_81097875</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0002914987903560</els_id><sourcerecordid>81097875</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-3958ef73bb67b8d5d3830e3e186e8acc1bbe4be81f613393209646e568241a6e3</originalsourceid><addsrcrecordid>eNp9kMFq3DAQhkVpSLZp36AFHUppDk40li1Ll0IJaRMI5JKchSSPd9V4LUfSpuzbV5td9tjTaDTf_AwfIZ-BXQIDccUYqysFjfouuwvFeCsq9o4sQHaqAgX8PVkckTPyIaU_pQVoxSk5raVitYIF8TcjuhzDvNomH8aw9I7iMJS_RMNAnV-aiDkjTevw7Kcl9ROdTfY4FeCvzytqpv7tETaZulUMU0mwmE1lx-CeMdK8wmjm7UdyMpgx4adDPSdPv24er2-r-4ffd9c_7yvHpcgVV63EoePWis7Kvu255Aw5ghQojXNgLTYWJQwCOFe8Zko0Alsh6waMQH5Ovu1z5xheNpiyXvvkcBzNhGGTtASmOtm1BWz2oIshpYiDnqNfm7jVwPTOsN7p0zt9Wnb6zbBmZe3LIX9j19gflw5Ky_zrYW6SM-MQzeR8OmJd2yquZMF-7DEsLl49Rp1cseqw97HY133w_7_jH2MTmKc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>81097875</pqid></control><display><type>article</type><title>Electrophysiologic effects of cigarette smoking in patients with and without chronic beta-blocker therapy</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Peters, Robert W. ; Benowitz, Neal L. ; Valenti, Steven ; Modin, Gunnard ; Fisher, Michael L.</creator><creatorcontrib>Peters, Robert W. ; Benowitz, Neal L. ; Valenti, Steven ; Modin, Gunnard ; Fisher, Michael L.</creatorcontrib><description>After refraining from smoking for at least 8 hours, 22 adult male habitual smokers underwent baseline electrophysiologic study including atrial and ventricular burst pacing and programmed premature stimulation with single extrastimuli. After smoking 2 of their usual brand of cigarettes in rapid succession, the electrophysiologic protocol was repeated. Nicotine, catecholamine and carbon monoxide concentrations all increased significantly. Smoking increased heart rate and improved atrioventricular conduction in the 13 patients receiving chronic β-blocker therapy (mostly for angina pectoris); increases in heart rate and improvement in atrioventricular conduction were not different statistically from those seen in patients not receiving β-blocker therapy, suggesting the possibility of a direct effect of nicotine or other components of tobacco smoke. Ventricular refractoriness was not altered and atrial and ventricular arrhythmias were not increased by smoking. Persistent sympathomimetic actions of cigarette smoking may explain in part the failure of β-blocking drugs to reduce cardiac mortality risk in smokers after myocardial infarction.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/0002-9149(87)90356-0</identifier><identifier>PMID: 2890291</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adrenergic beta-Antagonists - therapeutic use ; Adult ; Aged ; Arrhythmias, Cardiac - blood ; Arrhythmias, Cardiac - drug therapy ; Arrhythmias, Cardiac - physiopathology ; Atrioventricular Node - physiopathology ; Biological and medical sciences ; Humans ; Male ; Medical sciences ; Middle Aged ; Sinoatrial Node - physiopathology ; Smoking - blood ; Smoking - physiopathology ; Tobacco, tobacco smoking ; Toxicology</subject><ispartof>The American journal of cardiology, 1987-11, Vol.60 (13), p.1078-1082</ispartof><rights>1987</rights><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-3958ef73bb67b8d5d3830e3e186e8acc1bbe4be81f613393209646e568241a6e3</citedby><cites>FETCH-LOGICAL-c386t-3958ef73bb67b8d5d3830e3e186e8acc1bbe4be81f613393209646e568241a6e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0002-9149(87)90356-0$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7559398$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2890291$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peters, Robert W.</creatorcontrib><creatorcontrib>Benowitz, Neal L.</creatorcontrib><creatorcontrib>Valenti, Steven</creatorcontrib><creatorcontrib>Modin, Gunnard</creatorcontrib><creatorcontrib>Fisher, Michael L.</creatorcontrib><title>Electrophysiologic effects of cigarette smoking in patients with and without chronic beta-blocker therapy</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>After refraining from smoking for at least 8 hours, 22 adult male habitual smokers underwent baseline electrophysiologic study including atrial and ventricular burst pacing and programmed premature stimulation with single extrastimuli. After smoking 2 of their usual brand of cigarettes in rapid succession, the electrophysiologic protocol was repeated. Nicotine, catecholamine and carbon monoxide concentrations all increased significantly. Smoking increased heart rate and improved atrioventricular conduction in the 13 patients receiving chronic β-blocker therapy (mostly for angina pectoris); increases in heart rate and improvement in atrioventricular conduction were not different statistically from those seen in patients not receiving β-blocker therapy, suggesting the possibility of a direct effect of nicotine or other components of tobacco smoke. Ventricular refractoriness was not altered and atrial and ventricular arrhythmias were not increased by smoking. Persistent sympathomimetic actions of cigarette smoking may explain in part the failure of β-blocking drugs to reduce cardiac mortality risk in smokers after myocardial infarction.</description><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Adult</subject><subject>Aged</subject><subject>Arrhythmias, Cardiac - blood</subject><subject>Arrhythmias, Cardiac - drug therapy</subject><subject>Arrhythmias, Cardiac - physiopathology</subject><subject>Atrioventricular Node - physiopathology</subject><subject>Biological and medical sciences</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Sinoatrial Node - physiopathology</subject><subject>Smoking - blood</subject><subject>Smoking - physiopathology</subject><subject>Tobacco, tobacco smoking</subject><subject>Toxicology</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFq3DAQhkVpSLZp36AFHUppDk40li1Ll0IJaRMI5JKchSSPd9V4LUfSpuzbV5td9tjTaDTf_AwfIZ-BXQIDccUYqysFjfouuwvFeCsq9o4sQHaqAgX8PVkckTPyIaU_pQVoxSk5raVitYIF8TcjuhzDvNomH8aw9I7iMJS_RMNAnV-aiDkjTevw7Kcl9ROdTfY4FeCvzytqpv7tETaZulUMU0mwmE1lx-CeMdK8wmjm7UdyMpgx4adDPSdPv24er2-r-4ffd9c_7yvHpcgVV63EoePWis7Kvu255Aw5ghQojXNgLTYWJQwCOFe8Zko0Alsh6waMQH5Ovu1z5xheNpiyXvvkcBzNhGGTtASmOtm1BWz2oIshpYiDnqNfm7jVwPTOsN7p0zt9Wnb6zbBmZe3LIX9j19gflw5Ky_zrYW6SM-MQzeR8OmJd2yquZMF-7DEsLl49Rp1cseqw97HY133w_7_jH2MTmKc</recordid><startdate>19871101</startdate><enddate>19871101</enddate><creator>Peters, Robert W.</creator><creator>Benowitz, Neal L.</creator><creator>Valenti, Steven</creator><creator>Modin, Gunnard</creator><creator>Fisher, Michael L.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19871101</creationdate><title>Electrophysiologic effects of cigarette smoking in patients with and without chronic beta-blocker therapy</title><author>Peters, Robert W. ; Benowitz, Neal L. ; Valenti, Steven ; Modin, Gunnard ; Fisher, Michael L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-3958ef73bb67b8d5d3830e3e186e8acc1bbe4be81f613393209646e568241a6e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Adult</topic><topic>Aged</topic><topic>Arrhythmias, Cardiac - blood</topic><topic>Arrhythmias, Cardiac - drug therapy</topic><topic>Arrhythmias, Cardiac - physiopathology</topic><topic>Atrioventricular Node - physiopathology</topic><topic>Biological and medical sciences</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Sinoatrial Node - physiopathology</topic><topic>Smoking - blood</topic><topic>Smoking - physiopathology</topic><topic>Tobacco, tobacco smoking</topic><topic>Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peters, Robert W.</creatorcontrib><creatorcontrib>Benowitz, Neal L.</creatorcontrib><creatorcontrib>Valenti, Steven</creatorcontrib><creatorcontrib>Modin, Gunnard</creatorcontrib><creatorcontrib>Fisher, Michael L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peters, Robert W.</au><au>Benowitz, Neal L.</au><au>Valenti, Steven</au><au>Modin, Gunnard</au><au>Fisher, Michael L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Electrophysiologic effects of cigarette smoking in patients with and without chronic beta-blocker therapy</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>1987-11-01</date><risdate>1987</risdate><volume>60</volume><issue>13</issue><spage>1078</spage><epage>1082</epage><pages>1078-1082</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>After refraining from smoking for at least 8 hours, 22 adult male habitual smokers underwent baseline electrophysiologic study including atrial and ventricular burst pacing and programmed premature stimulation with single extrastimuli. After smoking 2 of their usual brand of cigarettes in rapid succession, the electrophysiologic protocol was repeated. Nicotine, catecholamine and carbon monoxide concentrations all increased significantly. Smoking increased heart rate and improved atrioventricular conduction in the 13 patients receiving chronic β-blocker therapy (mostly for angina pectoris); increases in heart rate and improvement in atrioventricular conduction were not different statistically from those seen in patients not receiving β-blocker therapy, suggesting the possibility of a direct effect of nicotine or other components of tobacco smoke. Ventricular refractoriness was not altered and atrial and ventricular arrhythmias were not increased by smoking. Persistent sympathomimetic actions of cigarette smoking may explain in part the failure of β-blocking drugs to reduce cardiac mortality risk in smokers after myocardial infarction.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>2890291</pmid><doi>10.1016/0002-9149(87)90356-0</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 1987-11, Vol.60 (13), p.1078-1082
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_miscellaneous_81097875
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adrenergic beta-Antagonists - therapeutic use
Adult
Aged
Arrhythmias, Cardiac - blood
Arrhythmias, Cardiac - drug therapy
Arrhythmias, Cardiac - physiopathology
Atrioventricular Node - physiopathology
Biological and medical sciences
Humans
Male
Medical sciences
Middle Aged
Sinoatrial Node - physiopathology
Smoking - blood
Smoking - physiopathology
Tobacco, tobacco smoking
Toxicology
title Electrophysiologic effects of cigarette smoking in patients with and without chronic beta-blocker therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T06%3A17%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Electrophysiologic%20effects%20of%20cigarette%20smoking%20in%20patients%20with%20and%20without%20chronic%20beta-blocker%20therapy&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Peters,%20Robert%20W.&rft.date=1987-11-01&rft.volume=60&rft.issue=13&rft.spage=1078&rft.epage=1082&rft.pages=1078-1082&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/0002-9149(87)90356-0&rft_dat=%3Cproquest_cross%3E81097875%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=81097875&rft_id=info:pmid/2890291&rft_els_id=0002914987903560&rfr_iscdi=true